GSE233679 nicotinamide 6 v 8 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE233679_nicotinamide_6_v_8_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE233679_nicotinamide_6_v_8_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE233679_nicotinamide_6_v_8_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE233679_nicotinamide_6_v_8_human_up.

Results found

Linked to

 

Label

Description

 

Gene

acetylserotonin O-methyltransferase like

Gene

growth arrest specific 5

Gene

H3.3 histone A

Gene

differentiation antagonizing non-protein coding RNA

Gene

small nucleolar RNA host gene 4

Gene

small nucleolar RNA host gene 7

Gene

long intergenic non-protein coding RNA 1963

Gene

long intergenic non-protein coding RNA 641

Gene

HHIP antisense RNA 1

Gene

prostate cancer associated transcript 7

  • Gene

    acetylserotonin O-methyltransferase like


  • Gene

    growth arrest specific 5



  • Gene

    differentiation antagonizing non-protein coding RNA


  • Gene

    small nucleolar RNA host gene 4


  • Gene

    small nucleolar RNA host gene 7


  • Gene

    long intergenic non-protein coding RNA 1963


  • Gene

    long intergenic non-protein coding RNA 641


  • Gene

    HHIP antisense RNA 1


  • Gene

    prostate cancer associated transcript 7

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.